Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance

British Journal of Clinical Pharmacology

Volumn 60, Issue 4, 2005, Pages 355-363

  Holmes, Andrew S ^a   Chirkov, Yuliy Y ^a   Willoughby, Scott R ^a   Poropat, Susan ^a   Pereira, Jeremy ^a   Horowitz, John D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Augmentation index; Nitrates; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; GLYCERYL TRINITRATE; ISOSORBIDE 5 NITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTERY TONE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG RESPONSE; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPNEA; EX VIVO STUDY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; IN VIVO STUDY; LONG TERM CARE; MALE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; SUSTAINED DRUG RELEASE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

AGED; ANGINA PECTORIS; BLOOD PLATELETS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DRUG RESISTANCE; FEMALE; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; PLATELET AGGREGATION; VASODILATOR AGENTS;

EID: 26444500967     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02437.x     Document Type: Article

References (32)

1. DeMots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 1989; 13: 786-95.
2. Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, Ibrahim R, Watts LE, Garutti RJ, Ferraresi R, Casareto R. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 1993; 72: 1249-56.
3. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 1996; 77: 31C-7C
4. Lam JY, Chesebro JH, Fuster V. Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug. Circulation 1988; 78: 712-6.
5. Folts JD, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation 1991; 83: 2122-7.
6. Stamler JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol 1991; 18: 1529-36.
7. Chirkov YY, Naujalis JI, Barber S, Sage RE, Gove DW, Brealey JK, Horowitz JD. Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects. Am J Cardiol 1992; 70: 802-6.
8. Karlberg KE, Torfgard K, Ahlner J, Sylven C. Dose-dependent effect of intravenous nitroglycerin on platelet aggregation, and correlation with plasma glyceryl dinitrate concentration in healthy men. Am J Cardiol 1992; 69: 802-5.
9. Diodati JG, Cannon RO, Hussain N, Quyyumi AA. Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris. Am J Cardiol 1995; 75: 443-8.
10. Wolfram G, Meyer U, Scheske U, Horn M, Drummer C, Spannagl M, Gerzer R. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man. Eur J Med Res 1996; 1: 291-8.
11. Horowitz JD. Role of nitrates in unstable angina pectoris. Am J Cardiol 1992; 70: 64B-71B.
12. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983; 68: 1247-53.
13. Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 1985; 76: 703-8.
14. Chirkov YY, Horowitz JD. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. J Cardiovasc Pharmacol 1996; 28: 375-80.
15. Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EM. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation 1988; 77: 787-94.
16. Chirkov YY, Chirkova LP, Horowitz JD. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 520-5.
17. Sage PR, de La Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, Horowitz JD. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 2000; 102: 2810-5.
18. Chirkov YY, Chirkova LP, Horowitz JD. Nitroglycerin tolerance at the platelet level in patients with angina pectoris. Am J Cardiol 1997; 80: 128-31.
19. Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 1999; 100: 129-34.
20. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995; 95: 187-94.
21. Westerbacka J, Tamminen M, Cockcroft J, Yki-Jarvinen H. Comparison of in vivo effects of nitroglycerin and insulin on the aortic pressure waveform. Eur J Clin Invest 2004; 34: 1-8.
22. Stepien JM, Prideaux RM, Willoughby SR, Chirkov YY, Horowitz JD. Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia. Clin Exp Pharmacol Physiol 2003; 30: 507-12.
23. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol 2001; 51: 507-22.
24. Wilkinson IB, Cockcroft JR, Webb DJ. Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 1998; 32(Suppl 3): S33-7.
25. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-52.
26. Chirkov YY, Naujalis JI, Sage RE, Horowitz JD. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol 1993; 21: 384-9.
27. Willoughby SR, Chirkova LP, Horowitz JD, Chirkov YY. Multiple agonist induction of aggregation: an approach to examine anti-aggregating effects in vitro. Platelets 1996; 7: 329-33.
28. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 1987; 76: 577-84.
29. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 1998; 338: 520-31.
30. Booth BP, Jacob S, Bauer JA, Fung HL. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. J Cardiovasc Pharmacol 1996; 28: 432-8.
31. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2002; 99: 8306-11.
32. Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mulsch A, Schulz E, Keaney JF, Stamler JS, Munzel T. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 2004; 113: 482-9.